Atlas Trials

Study of Pazopanib Monotherapy in Patients With Unresectable, Metastatic Neuroendocrine Tumor

Clinical trial NCT01099540 · COMPLETED

Trial details

NCT number
NCT01099540
Sponsor
Samsung Medical Center
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuroendocrine Tumor
Start date
2010-04-01
Primary completion
2012-03-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.